Cite

HARVARD Citation

    Morris, M. et al. (n.d.). 842PCTC-based biomarkers & PSMA-targeted imaging in patients with metastatic castrate-resistant prostate cancer (mCRPC). Annals of oncology. p. . [Online]. 
  
Back to record